i2E & Plains Ventures Surpasses $100M Milestone in Total Investments
Innovation 2 Enterprise
NOVEMBER 21, 2024
Selexys Pharmaceuticals was acquired by Novartis for $665 million in October 2016. By leveraging its extensive network and resources, i2E is committed to supporting innovation, driving economic development, and nurturing a thriving entrepreneurial community. Novazyme Pharmaceuticals Inc. was acquired by Genzyme Corp for $137.5
Let's personalize your content